• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

Spectrum of histopathological lesions in the prostate and their correlation with serum prostate specific antigen levels

    Dr. Priyanka Rani, Dr. Francis K Sridhar, Dr. Shekhar Baweja, Dr. Nalini Calton, Dr. Rupinder Kaur

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 2694-2703

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Diseases affecting  the  prostate  include  benign  prostatic  hyperplasia (BPH), non-specific inflammatory conditions and malignancy of the prostate, are responsible for significant  morbidity  and  mortality among  ageing male patients.This study was done to study the histopathological spectrum of prostatic lesions, classify them and to correlate them with free serum PSA levels.
Material and methods:The sample size was 302. Collected data was analyzed with descriptive statistics followed by chi- square test.Tests were used to analyze the sensitivity, specificity and overall accuracy of serum PSA levels in diagnosing benign and malignant prostatic lesions. p value was calculated and considered statistically significant when p value was less than 0.005.
Results:Majority of the benign lesions had serum PSA in the range of 0-4 ng/ml.About 21% had modest elevation in serum PSA.Majority of the malignant lesions had highly elevated serum PSA levels.BPH-Less than half of the cases showed epithelial and stromal hyperplasia without prostatitis.PIN- 2 had a histology of low grade PIN and 1 had high grade PIN. Adenocarcinoma: Majority of the lesions showed discrete glandular pattern.Gleason score of 7 was the commonest pattern. The sensitivity and specificity of serum PSA in benign lesions was found to be 62% and 95% respectively and in malignant lesions was 95% and 62% respectively.
Conclusion: It was concluded that PSA cut off value >4ng/ml is a diagnostic tool for detection of adenocarcinoma prostate.
Keywords:
    adenocarcinoma Prostate PSA levels
  • PDF (198 K)
  • XML
(2022). Spectrum of histopathological lesions in the prostate and their correlation with serum prostate specific antigen levels. European Journal of Molecular & Clinical Medicine, 9(3), 2694-2703.
Dr. Priyanka Rani, Dr. Francis K Sridhar, Dr. Shekhar Baweja, Dr. Nalini Calton, Dr. Rupinder Kaur. "Spectrum of histopathological lesions in the prostate and their correlation with serum prostate specific antigen levels". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 2694-2703.
(2022). 'Spectrum of histopathological lesions in the prostate and their correlation with serum prostate specific antigen levels', European Journal of Molecular & Clinical Medicine, 9(3), pp. 2694-2703.
Spectrum of histopathological lesions in the prostate and their correlation with serum prostate specific antigen levels. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 2694-2703.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 72
  • PDF Download: 99
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus